CAROLYN WEINSTEIN: Open Payments
NPI 1962453811 · WINTER PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 22 payments from 8 companies in 2025. Trend: 2023 $471 · 2024 $426 · 2025 $593
Food & beverage: $494Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $322 |
| Sumitomo Pharma America, Inc. | 5 | $84 |
| Exeltis, USA Inc. | 2 | $43 |
| Biogen, Inc. | 2 | $40 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
Products named: Veozah, MYFEMBREE, SLYND, ZURZUVAE, Mirena, Vanflyta, INJECTAFER, ACCRUFER.
Industry payments across FL — which companies pay providers there.
